Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects

Diabetes

Volumn 45, Issue 3 SUPPL., 1996, Pages

  Harano, Yutaka ^a   Kageyama, Aritsune ^a   Nakao, Yasuhiko ^a   Hara, Yasushi ^a   Suzuki, Masaaki ^a   Sato, Akira ^a   Ikebuchi, Motoyoshi ^a   Shinozaki, Kazuya ^a   Tsushima, Motoo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIET THERAPY; HUMAN; HYPERLIPOPROTEINEMIA; INSULIN TREATMENT; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; ARTERIOSCLEROSIS OBLITERANS; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TRIGLYCERIDES;

EID: 0029886686     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.s31     Document Type: Article

References (9)

1. Hatch FT, Lees RS: Practical method for plasma lipoprotein. Adv Lipid Res 6:1-68, 1968
2. Harano Y, Nakao Y, Kageyama A, Suzuki M, Hirose J, Asakura Y, Sato A, Komatsu R, Tsushima M, Yamamoto A: A contribution of hyperinsulinemia and hyperglycemia to lipoprotein disorder in obesity. In Progress in Obesity Research. Oomura Y, Tarui S, Inoue S, Shimazu T, Eds. London, Libby, 1990, p. 299-302
3. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR: Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 10:232-239, 1990
4. Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO Jr. Association of hyperapobetalipoprotcinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med 97:833-839, 1982
5. Fielding CJ, Reaven GM, Fielding PE: Human noninsulin-dependent diabetes; identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc Natl Acad Sci USA 79:6365-6369, 1982
6. Brunzell JD, Porte D Jr, Bierman EL: Abnormal lipoprotein lipase mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism 28:901-907, 1979
7. Harano Y, Kojima K, Kosugi K, Suzuki M, Hrada M, Nakano T, Hidaka H, Kashowagi A, Torii R, Taniguclii Y, Nishimori T, Yasuda Y, Shigeta Y: Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys. Diabetes Res Clin Pract 16:163-173, 1992
8. Brown WV: Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143-161, 1994
9. Steinbricher UP, Witztum JL: Glycosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130-134, 1984